127 related articles for article (PubMed ID: 30383904)
1. Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
Li J; Ho WY; Tsang JYS; Ni YB; Chan SK; Tse GM
Histopathology; 2019 Mar; 74(4):567-577. PubMed ID: 30383904
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.
Bredemeier M; Kasimir-Bauer S; Kolberg HC; Herold T; Synoracki S; Hauch S; Edimiris P; Bankfalvi A; Tewes M; Kimmig R; Aktas B
Mol Med Rep; 2017 May; 15(5):2957-2968. PubMed ID: 28358430
[TBL] [Abstract][Full Text] [Related]
3. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours.
Karim RZ; Scolyer RA; Tse GM; Tan PH; Putti TC; Lee CS
Pathology; 2009 Feb; 41(2):105-17. PubMed ID: 19152185
[TBL] [Abstract][Full Text] [Related]
5. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Chougule A; Bal A; Das A; Kohli PS; Singh G
Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
7. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
Tan WJ; Thike AA; Bay BH; Tan PH
Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
[TBL] [Abstract][Full Text] [Related]
13. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
[TBL] [Abstract][Full Text] [Related]
14. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
Tan PH
Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
[TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT pathway activation in bladder carcinogenesis.
Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
[TBL] [Abstract][Full Text] [Related]
17. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
18. Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.
Tsang JY; Mendoza P; Lam CC; Yu AM; Putti TC; Karim RZ; Scolyer RA; Lee CS; Tan PH; Tse GM
Histopathology; 2012 Oct; 61(4):667-74. PubMed ID: 22571452
[TBL] [Abstract][Full Text] [Related]
19. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.
Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK
Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099
[TBL] [Abstract][Full Text] [Related]
20. Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breast.
Mihai R; Callagy G; Qassid OL; Loughlin MO; Al-Hilfi L; Abbas A; Campora M; Hodi Z; Ellis I; Lee AHS; Rakha EA
Histopathology; 2021 May; 78(6):871-881. PubMed ID: 33325544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
